The threat of antimicrobial resistance in developing countries: causes and control strategies.

Ayukekbong JA, Ntemgwa M, Atabe AN. · 2017

Read The threat of antimicrobial resistance in developing countries: causes and control strategies. by Ayukekbong JA, Ntemgwa M, Atabe AN. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5433038.txt.

Introduction

Ayukekbong and co-authors map why drug-resistant infections hit developing countries so hard. Their review appeared in Antimicrobial Resistance and Infection Control. Germs grow resistant wherever antimicrobials are used. Misuse speeds the process greatly. In poorer countries, misuse is easy. Drugs sell over the counter with no prescription. Untrained street vendors dispense them. Weak regulators fail to police the supply chain.

Poverty shapes patient behavior too. People buy partial courses they can afford. They stop when symptoms fade. Survivors of that weak dose can gain resistance. Self-treatment and herbal first aid add to the risk. Clinics often lack labs to guide prescribing. Farm use of antimicrobials adds another stream. The authors walk the chain from production to consumption. Each weak link gets named. They then discuss prevention and other control options. Fixes, they argue, must fit local causes, not copy rich-country plans.

Catalog record

CREATORAyukekbong JA, Ntemgwa M, Atabe AN.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5433038

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The threat of antimicrobial resistance in developing countries: causes and control strategies By James A. Ayukekbong, Michel Ntemgwa, Andrew N. Atabe Published in: Antimicrobial Resistance and Infection Control DOI: 10.1186/s13756-017-0208-x ABSTRACT The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients’ behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring. BACKGROUND The threat of antimicrobial resistance (AMR) is growing at an alarming rate and the situation is perhaps aggravated in developing countries due to gross abuse in the use of antimicrobials [1]. It is well known that any use of antimicrobials however appropriate and justified, contributes to the development of resistance, but widespread unnecessary and excessive use makes the situation worse [2]. Misuse of antimicrobials is facilitated in developing countries by their availability over the counter, without prescription and through unregulated supply chains [1, 3]. Non-compliance in the use of antimicrobials has many repercussions upon resistance and poverty is a major root factor of antimicrobial misuse in developing countries [4]. On the other hand, even among the rich, some patients miss doses either by mistake or deliberate, especially in cases where signs and symptoms begin to subside after an initial favorable therapeutic response [5]. In other situations, such as in the event of an acute side effect, patients abandon their treatment, only to return to the hospital with a recurring infection by a more virulent and resistant strain of the microbe [6]. These actions result in the exposure of surviving pathogens to sub-therapeutic concentrations of antimicrobials thus increasing the chances of acquiring resistance. Self-medication is a common practice in developing countries where patients often get antimicrobials without prescription and through unregulated supply chains [7]. To make the situation even worst, some patients seek their first-line of treatment from traditional healers who provide them with herbal combinations for the treatment of infections. These substances of unknown composition and potency may enhance pathogen fitness and contribute to the development of resistance. Antimicrobial resistance often occur through the inhibition of specific antimicrobial pathways such as cell wall synthesis, nucleic acid synthesis, ribosome function, protein synthesis, folate metabolism, and cell membrane function [8–10]. Causes of antimicrobial resistance To better appreciate the causes of AMR, we need to understand the various sequential steps involved for a drug to get to a patient and the eventual use, which include; production, distribution, prescription, dispensing, and finally consumption of the drug by the patient or use in animal production [11]. Consequently, any imprudent practice along this flow may result in the emergence of resistance. Drug dispensers and drug quality The lack of appropriate regulations in the sales of antimicrobials is also a driving factor in the access and misuse of antimicrobials. In most developing countries, antimicrobials can be purchased without medical prescription [12] and are usually dispensed on the streets by untrained persons. These drug vendors will sell medications just to make a sale and accommodate patients’ ability to pay [13]. Even pharmacies operating without a license, appear to be more accessible to the public as they have shorter waiting time, do not charge consultation fees and above all are willing to negotiate treatment options to adjust to the financial ability of the patients [14]. Retail pharmacies in developing countries especially in Africa have emerged as the primary level of outpatient care rendering unauthorized services from consultation, diagnosis, prescription and dispensing of medication [14, 15]. It has also been shown that many antimicrobials dispensed in Africa are of questionable pharmacological quality [16, 17]. Adverse climatic conditions such as high ambient temperatures and humidity may affect the overall quality of the antimicrobials during storage [18, 19]. Poor storage also increases the risk of degradation of the drug. Degraded medicines contain less than stated dose, implying that patients consume less than optimal dose of the drug. There is also a problem of outright counterfeit, in which the drug may contain little or no active substance of the antimicrobial or the wrong substance [20]. The influx of counterfeit and sub-standard antimicrobials into the pharmaceutical markets in some regions is a major problem as these preparations of reduced potency also result in pathogens being exposed to sub-therapeutic concentrations of the drug [21]. A study from Cameroon revealed that, out of 284 antimalarial obtained from 132 vendors, 32% of chloroquine, 10% quinine, and 13% sulfadoxine/pyrimethamine were likely to be fake [16]. In addition, some of the quinine contained chloroquine while some chloroquine contained no active ingredient or an amount lower than the expected concentration. Health professionals Health care providers play an essential role in the treatment and prevention of diseases, but may jeopardize this if their practices are not evidence-based (Table 1). For example, the prescription practices of antimicrobials vary among physicians in most countries. In some cases, the antimicrobial prescriptions are inappropriate (i.e., wrong drug, wrong doses, or antimicrobial not necessary at all) [22]. Due to the high patient-doctor ratio in most developing countries, doctors are overwhelmed and there is often inadequate time for meaningful education and communication with the patient on drug adherence guidelines and consequences of poor or non-adherence to these guidelines. Treatment sometimes consists of administering broad-spectrum antibiotics without a definitive diagnosis and indication for antimicrobial treatment. In a Lebanese study, it was shown that in 52% of cases, the prescription dose was inappropriate while 63.7% of physicians prescribed antibiotics with wrong duration of treatment [23].Table 1Factors and stakeholders contributing to the problem of antimicrobial resistanceFactorsContributionExamplePoor drug qualitySales of counterfeit, adulterated and poor quality antibioticsThese poor quality antibiotics can produce sub-inhibitory concentration in vivo, which increases the selection of resistant strainsRegulatorsWhile most developed countries have developed AMR action plans, this is still lacking in many developing countries especially in AfricaMost countries lack the resources to enforce policies regarding the manufacture and distribution of sub-standard drugsPrescribersExcessive clinical use and misuse is partially responsible for increase rate of resistanceVariation in prescription practice among health care provider. Sometimes there is prescription of a wrong drug, wrong doses, or antimicrobial not necessary at allDispensersDrug vendors usually have little or no knowledge of the required dosage regimen, indication, or contraindicationsMedications are usually purchased in small aliquots from roadside stall and storage and distribution is usually done under inadequate conditionsUsers (patients)High rate of self- medication and lack of treatment compliancePatients fail to adhere to dosage regimens and discontinue treatment when symptoms subside before pathogen is eliminatedAnimal industryThe use of antimicrobial drugs in agriculture or industrial settings, exerts a selection pressure which can

Read the complete text